Effective April 21:
Naproxen sodium 220 mg per oral dosage unit (when sold in products labeled with a recommended maximum daily dose of 440 mg, and in package sizes exceeding 6,600 mg) is now Schedule III (changed from Schedule II).
ACP launches CQI+
January 21, 2025
Empowering safety culture in pharmacy practice.
Read more ➞